ABVC BioPharma, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-736.9K | $-1.6M | $-2.0M | $-2.3M | $-842.1K | $-394.8K | $-942.3K | $-2.8M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $12.3K | $5.8K | $25.3K | $13.7K | $7.0K | $28.6K | $13.3K | $1.3K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $253.0K | $787.4K | $1.1M | $1.6M | $48.8K | $95.9K | $282.9K | $2.0M |
| Net Cash from Operating Activities | $-244.4K | $-894.2K | $-964.7K | $-894.2K | $-539.8K | $60.2K | $-211.4K | $-955.8K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $47.1K | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-342.2K | — | — | $428.8K | — | — | $924.1K |
| Net Change in Cash | — | $-1.2M | — | — | $-104.2K | — | — | $-57.8K |
| Free Cash Flow | — | — | — | — | — | — | — | — |